Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction

Guglielmo Gallone, Anna Palmisano, Luca Baldetti, Caterina Beatrice Monti, Francesco Ponticelli, Giorgos Tzanis, Antonio Colombo, Antonio Esposito, Francesco Giannini

Research output: Contribution to journalArticlepeer-review

Abstract

The coronary sinus Reducer represents a novel therapeutic option with established safety and clinical benefit in the treatment of patients with refractory angina, possibly achieved by enhancing perfusion of myocardial ischemic territories. We report the first case providing insight on how improved perfusion might translate into improved myocardial function as assessed by cardiac magnetic resonance strain imaging, thus suggesting a physiological rationale to test coronary sinus Reducer in the setting of ischemic cardiomyopathy with reduced ejection fraction and adverse remodelling.

Original languageEnglish
Pages (from-to)589.e1-589.e4
JournalCanadian Journal of Cardiology
Volume36
Issue number4
DOIs
Publication statusPublished - Apr 2020

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Improved Myocardial Function With Coronary Sinus Reducer in a Patient With Refractory Angina and Heart Failure With Reduced Ejection Fraction'. Together they form a unique fingerprint.

Cite this